Effects of electroacupuncture at "Fenglong" (ST 40) on NO, ET and CGRP levels in the rat with hyperlipidemia.
- Author:
Li ZHOU
1
;
Wen-jun WAN
;
Ling-guang LIU
;
Xuan LI
;
Hong-xing ZHANG
;
Tang-fa ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Acupuncture Points; Animals; Calcitonin Gene-Related Peptide; blood; Cholesterol, HDL; blood; Cholesterol, LDL; blood; Electroacupuncture; Endothelins; blood; Hyperlipidemias; blood; therapy; Male; Nitric Oxide; blood; Rats; Rats, Wistar
- From: Chinese Acupuncture & Moxibustion 2008;28(1):57-60
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo probe the regulative effect of electroacupuncture (EA) at "Fenglong" (ST 40) on blood lipids in hyperlipidemia (HLP) rats and the mechanism.
METHODSEighty Wistar rats were randomly divided into a normal group (fed with basal forage), a model group (fed with high fat forage), an EA group (fed with high fat forage + EA treatment), a western medicine group (fed with high fat forage + Pravastatin sodium). Contents of serum total cholesterol (TC), triacylglycerol (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), endothelin (ET), nitric oxide (NO) and calcitonin gene-related peptide (CGRP) were determined before and after treatment.
RESULTSCompared with the normal group, the body weight, levels of TC, TG, LDL-C and ET were significantly elevated (P < 0.05, P < 0.01) and the levels of HDL-C, NO and CGRP were significantly decreased (P < 0.05) in the model group; compared with the model group, the body weight, levels of TC, TG and LDL-C were significantly decreased (P < 0.01) and the levels of NO and CGRP were significantly increased in the western medicine group and the EA group (P < 0.01, P < 0.05); compared with the EA group, HDL-C level significantly increased in the western medicine group (P < 0.01), and ET level decreased in the EA group and the western medicine group with no significant difference between the two groups (P > 0.05).
CONCLUSIONBoth EA and Pravastatin sodium have better benign regulative effects on TC, TG, LDL-C, NO and CGRP and can decrease ET level to a certain extent in the rat of hyperlipidemia.